Introduction Neurodegenerative diseases are a heterogenous group of neurological disorders characterized by the progressive loss of selective neuronal populations in the nervous system, giving rise to distinct clinical features, such as cognitive, behavioral, and motor symptoms (Wilson et al., 2023
Results announced in October 2025 demonstrated orforglipron's superiority on both HbA1c and weight endpoints, positioning it as a more effective second-line oral agent than existing oral diabetes medications
[4] [5] However, whilst Ozempic won't show up as a distinct marker on standard blood panels, the medication does influence various metabolic parameters that blood tests measure
Cell 178 , 795806.e712 (2019)
Leu [edit] Leu activates GLUD1 independently of the ADP, possessing a special allosteric site in the subunits interface area 8AR7